GeneFerm Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 368.303 million compared to TWD 328.230 million a year ago. Operating income was TWD 17.120 million compared to operating loss of TWD 23.378 million a year ago. Net income was TWD 4.529 million compared to net loss of TWD 27.550 million a year ago. Basic earnings per share was TWD 0.16 compared to basic loss per share of TWD 0.99 a year ago.